The accuracy of non-invasive radionuclide angiography in detecting portal vein occlusion was assessed in 61 patients -10 with portal vein occlusion confirmed by conventional portography, 25 with chronic liver disease and a patent portal vein (mild=12, severe=13), and 26 with normal liver function, who served as controls. The median percentage portal venous flow for the portal vein occlusion group was 8% (range 1-30) (consistent with negligible flow) compared with 78% (52-87) for control subjects (p<0.005) and 68% (61-80) and 49% (23-59) respectively for patients with mild and severe liver disease (p<0.001 and p<0.005). At a portal venous inflow of <20%, the proceedure had a specificity of 100% and sensitivity of 90% in diagnosing portal vein occlusion. Non-invasive radionuclide angiography provides a safe and accurate screening method for evaluating portal vein patency or occlusion in the investigation of portal hypertension or before liver transplantation.
Complete or partial occlusion of the portal vein is a common cause of portal hypertension in childhood. ' 
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conventional arterial portography or splenoportography with additional conclusive evidence from laparotomy and post mortem examination in two cases (see Table II ). In three patients there was coexisting liver disease and in one of these patients (patient 9), the PVO was associated with the development of hepatocellular carcinoma. Pancreatitis (patient 3) and polycythaemia rubra vera (PRV) (patient 6), accounted for two other cases while no cause was evident in the remaining five patients (idiopathic). Preliminary data analysis involved a summation of the initial 30 images to form a composite image outlining the arterial phase of tracer transit through the hepatobiliary system. Regions of interest (ROIs) were drawn over the liver, spleen, lungs, and left kidney ensuring that the liver ROI excluded the descending aorta and right kidney (Fig 1) . The ROIs were then used to generate time-activity curves (TACs). Because of interference from the right lung into the liver ROI, a correction factor was applied to take account of this 'cross-talk', resulting in a corrected liver TAC (Fig 1) . Deconvolution analysis of the TACs was used to improve separation of the arterial and portal venous phases of total liver blood flow. In addition, this method takes account of tracer recirculation and therefore allows analysis of the deconvoluted curves by area under the curve as a measure of blood flow. The liver, spleen, and left kidney TACs were deconvoluted with the lung curve using a modified fast Fourier transform technique as described by Juni et al. ' 3 If the assumption is made on an anatomical basis, that blood flow through the splenic artery has a similar pattern to hepatic arterial flow, then the splenic TAC can be used as a model for hepatic arterial flow. In order to compensate for differences in absolute flow and in attenuation by overlying tissues, the splenic TAC was multiplied by a constant so that the upslope of the splenic TAC overlies the early segment of the total liver TAC (Fig 2) . Thus, the modified splenic TAC approximates to the hepatic arterial TAC. The liver and modified splenic TAC are then integrated to yield the areas under the curve, AL and As, respectively (Fig 2) patients with coexisting cavernous transformation of the portal vein were excluded, the calculated % PV was further reduced to 3% (range 1-10). Only the three patients with cavernous transformation had a % PV flow of more than 10% (11%, 18%, and 30% respectively) (Table  III) . Figure 3 illustrates the differences in % PV flow between the patients with PVO and the two control groups (2 and 3). The % PV flow for control subjects (group 3) was 78% (range, 53-86) which is consistent with known physiological estimates. '4 In group 2, a progressive reduction in the % PV contribution with increasing severity of liver disease was observed, from 68% in patients with mild disease (range 61-80) (p>0-10 v controls) to 49% in the group with severe disease (range 22-61) (p<0001 v controls). In two patients with decompensated cirrhosis (Child-Pugh score C12&13), the % PV flow was 23% and 28%, respectively. The % PV flow was significantly reduced in the PVO group when compared with both control groups 2 and 3 (p<0-0001 v controls, p<0.001 v mild, and p<0 005 v severe liver disease (Fig 3) ).
For a % PV flow of 20% or less, the specificity and sensitivity of this proceedure in accurately detecting PVO were 100% and 90%, respectively. At a % PV flow of 30% or less, the specificity was reduced to 85% while the sensitivity was increased to 100% Discussion Confirmation of portal vein patency or occlusion relies predominantly upon venous phase arterial portography or splenoportography, both invasive and time consuming radiological procedures that may have complications. Several investigators have attempted to define the portal venous and hepatic arterial contributions to total liver blood flow by non-invasive means including ultrasound78 and radionuclide angiography. "" -18 The degree of portasystemic shunting in cirrhosis has also been examined by scintigraphy, however per rectal administration of the radionuclide is required. 2 Secondly, a major reduction in portal venous inflow to the liver associated with reversed (caudal) blood flow, may occur in the absence of obstruction within the portal venous system,22 as observed in two of the patients with decompensated alcoholic cirrhosis with % PV flows of 28% and 23% respectively (Fig 3) . Consequently, % PV flow values of between 20 
